FDA Q&A - Putting it into practice

The FDA recently published Q&A guidance on Risk-Based approaches to monitoring of clinical investigations. 

In this webinar we will be running through the key points from the answers of each of the 8 questions, as well as discussing how we help clients deliver these answers using our RBQM technology, OPRA.